Emergent BioSolutions Inc. (LON: 0IGA)
London
· Delayed Price · Currency is GBP · Price in USD
11.28
+0.28 (2.55%)
At close: Jan 31, 2025
Emergent BioSolutions Employees
Emergent BioSolutions had 1,600 employees as of December 31, 2023. The number of employees decreased by 900 or -36.00% compared to the previous year.
Employees
1,600
Change (1Y)
-900
Growth (1Y)
-36.00%
Revenue / Employee
524.83K GBP
Profits / Employee
-97.37K GBP
Market Cap
490.41M
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Emergent BioSolutions News
- 17 days ago - Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA) - GlobeNewsWire
- 19 days ago - Hikma Pharmaceuticals Partners with Emergent BioSolutions for KLOXXADO® Nasal Spray Distribution - GuruFocus
- 19 days ago - Emergent BioSolutions: Stock Is A Likely Winner In 2025 - Seeking Alpha
- 19 days ago - Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg - Benzinga
- 19 days ago - Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals - GlobeNewsWire
- 20 days ago - Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola - GlobeNewsWire
- 25 days ago - Emergent BioSolutions exercises $20M option to supply DoD with BioThrax - Seeking Alpha
- 25 days ago - Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025 - GlobeNewsWire